Autologous Stem Cell Transplantation for Crohn's Disease
Public ClinicalTrials.gov record NCT00692939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Pediatric and Adult Patients With Severe Crohn's Disease
Study identification
- NCT ID
- NCT00692939
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Paul Szabolcs
- Other
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Interventions
- ATG Drug
- Alemtuzumab Drug
- Cyclophosphamide Drug
- G-CSF Drug
- Melphalan Drug
- Mesna Drug
- Rituximab Drug
- Thiotepa Drug
- autologous CD34-selected peripheral blood stem cells transplant Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 10 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 25, 2012
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2027
- Last update posted
- Dec 14, 2025
2012 – 2027
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UPMC Prebyterian- Adult Gastroenterology | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team | Pittsburgh | Pennsylvania | 15224 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00692939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2025 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00692939 live on ClinicalTrials.gov.